Lipoprotein apheresis as a method of choice in the treatment of patients with severe hypercholesterolaemia

Abstract

Lipoprotein apheresis, one of the extracorporeal elimination methodologies, combined with higher doses of statins and ezetimibe, is the most effective way to treat homozygotes and statin-refractory heterozygotes of familial hypercholesterolaemia. Promising in particular is the potential for further reduction of LDL-cholesterol-lowering between apheresis.

Keywords

• lipoprotein
• LDL-cholesterolemia